Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Humana believes the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a 'Fee for Service Adjuster' and could have a material adverse effect on the company's operating results, financial position and cash flows.

  80% confidence

• The decline in Star Ratings will negatively impact its 2026 quality bonus payments from Centers for Medicare and Medicaid Services and may also significantly adversely affect the company's revenues, operating results, and cash flows if the lawsuit appeal is not successful.

  80% confidence

• The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program.

  80% confidence

• The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters' discounts and estimated offering expenses.

  80% confidence

Cited in these Via News reports

• Global M&A Activity Hits $15B+ as Consumer and Financial Sectors Drive Deal Surge →